Riskpilot← Back to searchSign inGet full accessPerbio Science AB
ABActiveOrg 5565670626Activities of holding companies · NACE 6421Est. 19990 employees
Revenue 2024
SEK 0
EBITDA margin
—
+35% vs 2023
Equity ratio
95.6%
Financial strength
Net profit 2024
SEK -79,3M
-101% vs 2023
| Revenue | SEK 0 | — |
| EBITDA | SEK -609K | +35% |
| Net profit | SEK -79,3M | -101% |
| Total assets | SEK 54,2B | +0% |
| Equity | SEK 51,8B | +0% |
| Employees | 0 | — |
Legal name
Perbio Science AB
Org number
5565670626
Legal form
Aktiebolag
NACE code
6421 · Activities of holding companies
Founded
17 februari 1999
Share capital
SEK 184 405 000
Employees
0
VAT registered
No
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
Firman tecknas av styrelsen Firman tecknas två i förening av ledamöterna
Company purpose
Bolaget har till föremål för sin verksamhet att, själv eller genom hel- eller delägda bolag utveckla, tillverka, marknadsföra och försälja biotekniska och medicintekniska produkter, äga och förvalta aktier i dotterbolag samt bedriva därmed förenlig verksamhet.
Address
Phone
+4642269090
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2016 | 2017 | 2018 | 2019 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | — | — | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Staff expenses | — | — | — | — | — | — | — | — | — | — |
| EBITDA | −822 | −603 | −532 | −1 000 | −74 | −701 | 1 400 | −768 | −930 | −609 |
| Depreciation & amort. | −3 | −0 | −0 | −0 | −0 | −0 | −0 | −0 | −0 | −0 |
| EBIT | −825 | −603 | −532 | −1 000 | −74 | −701 | 1 400 | −768 | −930 | −609 |
| Net financials | −136 357 | −127 927 | −122 453 | 15 883 000 | 156 291 | 3 272 752 | 320 440 | 170 332 | 6 689 883 | −79 077 |
| Profit before tax | −133 307 | −125 035 | −122 985 | 15 883 000 | 156 217 | 3 272 051 | 321 840 | 169 564 | 6 688 953 | −79 686 |
| Tax | −4 311 | −1 074 | −1 813 | 1 000 | −0 | −1 363 | −0 | 2 080 | 153 215 | 392 |
| Net profit | −137 618 | −126 109 | −124 798 | 15 884 000 | 156 217 | 3 270 688 | 321 840 | 171 644 | 6 842 168 | −79 294 |
| Item | 2016 | 2017 | 2018 | 2019 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|---|---|---|
| Total assets | 36 439 776 | 36 443 454 | 36 997 779 | 46 742 000 | 46 898 598 | 50 128 067 | 50 125 888 | 53 998 008 | 54 100 959 | 54 236 783 |
| Equity | 27 651 341 | 27 525 232 | 27 956 865 | 44 093 000 | 44 249 163 | 47 519 852 | 47 841 691 | 51 698 377 | 51 782 651 | 51 840 105 |
| Long-term debt | 6 679 158 | 6 805 604 | 6 906 863 | 511 000 | 511 688 | 520 823 | 210 004 | 185 000 | 185 000 | 193 566 |
| Short-term debt | 2 109 277 | 2 112 618 | 2 134 051 | 2 138 000 | 2 137 747 | 2 087 392 | 2 074 193 | 2 114 631 | 2 133 308 | 2 203 112 |
| Total debt | 8 788 435 | 8 918 222 | 9 040 914 | 2 649 000 | 2 649 435 | 2 608 215 | 2 284 197 | 2 299 631 | 2 318 308 | 2 396 678 |
EBITDA margin
-60900000.0%
This company
15.8%
Market median
-385443138% vs market
20162024
Equity ratio
95.6%
This company
38.2%
Market median
+150% vs market
20162024
Return on equity
-0.2%
This company
18.4%
Market median
-101% vs market
20162024
Net profit margin
-7929400000.0%
This company
8.1%
Market median
-97893827260% vs market
20162024
Asset turnover
0.00×
This company
1.12×
Market median
-100% vs market
20162024
Debt / equity
0.05×
This company
0.62×
Market median
+92% vs market
20162024
- Annual report 2024Filed via Bolagsverket / SCB · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Bolagsverket / SCB · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Bolagsverket / SCB · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Bolagsverket / SCB · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via Bolagsverket / SCB · Period 2020-01-01 – 2020-12-31
- Annual report 2019Filed via Bolagsverket / SCB · Period 2019-12-01 – 2019-12-31
- Annual report 2019Filed via Bolagsverket / SCB · Period 2018-12-01 – 2019-11-30
- Annual report 2018Filed via Bolagsverket / SCB · Period 2018-01-01 – 2018-11-30
- Annual report 2017Filed via Bolagsverket / SCB · Period 2017-01-01 – 2017-12-31
- Annual report 2016Filed via Bolagsverket / SCB · Period 2016-01-01 – 2016-12-31
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
HC Authorized Recipient of Service | Authorized Recipient of Service | 2021 | — | — |
TM Chief Auditor | Chief Auditor | 2022 | — | — |
VG Authorized Recipient of Service | Authorized Recipient of Service | 2022 | — | — |
EE Authorized Recipient of Service | Authorized Recipient of Service | 2022 | — | — |
AG Chief Auditor | Chief Auditor | 2021 | — | — |
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
| Board of Directors | 2021 | — | — | |
| Board of Directors | 2022 | — | — | |
| Board of Directors | 2021 | — | — | |
| Chairman | 2021 | — | — |
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
Fsii Sweden Holdings AB | Company | 100.0% | 100.0% | 2023 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
Fsii Sweden Holdings i ABPower Sweden Holdings i AktiebolagFsii Sweden Holdings AB
Perbio Science AB (this company)Tfs Life Investments Ii SarlTfs Prb SarlTFS LIFE INVESTMENTS II SARLPhadia Luxembourg Holdings SarlHYCLONE UK LTDFisher Scientific Biotech ApsPerbio Science Nederland BvHyclone Uk LtdFISHER SCIENTIFIC BIOTECH APSTFS PRB SARLBoard members of Perbio Science AB also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Hanna Chainikova | Authorized Recipient of Service | 0 companies |
| Torbjörn Mikael Åberg | Chief Auditor | 0 companies |
| Valerio Gaddi | Authorized Recipient of Service | 0 companies |
| Elias Ego | Authorized Recipient of Service | 0 companies |
| Anders Göran Magnussen | Chief Auditor | 0 companies |
| Marcel Jacobus van der Meijden | Board of Directors | 0 companies |
| Bram Monster | Board of Directors | 0 companies |
| Anthony Hugh Smith | Board of Directors | 0 companies |
| Petrus Thomas Adrianus van der Zande | Chairman | 0 companies |